Growth factors, their receptors and down-stream signaling proteins in human tumors: from experiment to clinical practice

Tekijä E. S. Gershtein, N. E. Kushlinsky
Julkaistu 2015-06-01

RANK/RANKL/OPG LIGAND-RECEPTOR SYSTEM AND ITS ROLE IN PRIMARY BONE NEOPLASMS (LITERATURE ANALYSIS AND OWN DATA)

Tekijä E. S. Gershtein, Yu. S. Timofeev, A. A. Zuev, N. E. Kushlinskii
Julkaistu 2015-12-01

CLINICAL PERSPECTIVES FOR STUDYING THE NUCLEAR TRANSCRIPTION FACTOR NF-κB IN BREAST CANCER

Tekijä E. S. Gershtein, A. M. Platova, V. P. Letyagin, N. E. Kushlinsky
Julkaistu 2014-09-01

Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer

Tekijä E. A. Kim, I. V. Vysotskaya, N. E. Kushlinsky, V. P. Letyagin, E. S. Gershtein
Julkaistu 2014-08-01

Modern approaches to kidney cancer immunotherapy

Tekijä N. E. Kushlinskii, M. V. Fridman, A. A. Morozov, E. S. Gershtein, Z. G. Kadagidze, V. B. Matveev
Julkaistu 2018-06-01

Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients

Tekijä E. S. Gershtein, D. S. Naberezhnov, A. A. Alferov, Svetlana D. Bezhanova, N. F. Frolova, V. B. Matveev, N. E. Kuslinskii
Julkaistu 2020-12-01

Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations

Tekijä N. E. Kushlinskii, E. S. Gershtein, I. O. Goryatcheva, A. A. Morozov, A. A. Alferov, S. D. Bezhanova, I. A. Kazantseva, V. V. Bazaev, V. B. Matveev
Julkaistu 2019-03-01